Bringuier PP - Search Results

1

Complex cadherin expression in renal cell carcinoma.

Shimazui T, Giroldi LA, Bringuier PP, Oosterwijk E, Schalken JA. Shimazui T, et al. Among authors: bringuier pp. Cancer Res. 1996 Jul 15;56(14):3234-7. Cancer Res. 1996. PMID: 8764114

2

Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma.

Shimazui T, Oosterwijk E, Akaza H, Bringuier P, Ruijter E, van Berkel H, Wakka JO, van Bokhoven A, Debruyne FM, Schalken JA. Shimazui T, et al. Clin Cancer Res. 1998 Oct;4(10):2419-24. Clin Cancer Res. 1998. PMID: 9796973

3

Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.

Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HF, Oosterhof GO, Debruyne FM, Schalken JA. Umbas R, et al. Among authors: bringuier pp. Cancer Res. 1994 Jul 15;54(14):3929-33. Cancer Res. 1994. PMID: 7518346

4

Defective E-cadherin function in urological cancers: clinical implications and molecular mechanisms.

Giroldi LA, Bringuier PP, Schalken JA. Giroldi LA, et al. Among authors: bringuier pp. Invasion Metastasis. 1994-1995;14(1-6):71-81. Invasion Metastasis. 1994. PMID: 7657535 Review.

5

Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors.

Bringuier PP, Umbas R, Schaafsma HE, Karthaus HF, Debruyne FM, Schalken JA. Bringuier PP, et al. Cancer Res. 1993 Jul 15;53(14):3241-5. Cancer Res. 1993. PMID: 8324734

6

Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.

Shimazui T, Schalken JA, Giroldi LA, Jansen CF, Akaza H, Koiso K, Debruyne FM, Bringuier PP. Shimazui T, et al. Among authors: bringuier pp. Cancer Res. 1996 Sep 15;56(18):4154-8. Cancer Res. 1996. PMID: 8797585

7

Relation between aberrant alpha-catenin expression and loss of E-cadherin function in prostate cancer.

Umbas R, Isaacs WB, Bringuier PP, Xue Y, Debruyne FM, Schalken JA. Umbas R, et al. Among authors: bringuier pp. Int J Cancer. 1997 Aug 22;74(4):374-7. doi: 10.1002/(sici)1097-0215(19970822)74:4<374::aid-ijc2>3.0.co;2-s. Int J Cancer. 1997. PMID: 9291424

8

Decreased expression of alpha-catenin is associated with poor prognosis of patients with localized renal cell carcinoma.

Shimazui T, Bringuier PP, van Berkel H, Ruijter E, Akaza H, Debruyne FM, Oosterwijk E, Schalken JA. Shimazui T, et al. Among authors: bringuier pp. Int J Cancer. 1997 Oct 21;74(5):523-8. doi: 10.1002/(sici)1097-0215(19971021)74:5<523::aid-ijc8>3.0.co;2-5. Int J Cancer. 1997. PMID: 9355975

9

Role of E boxes in the repression of E-cadherin expression.

Giroldi LA, Bringuier PP, de Weijert M, Jansen C, van Bokhoven A, Schalken JA. Giroldi LA, et al. Among authors: bringuier pp. Biochem Biophys Res Commun. 1997 Dec 18;241(2):453-8. doi: 10.1006/bbrc.1997.7831. Biochem Biophys Res Commun. 1997. PMID: 9425291

10

Changes in cadherin-catenin complexes in the progression of human bladder carcinoma.

Giroldi LA, Bringuier PP, Shimazui T, Jansen K, Schalken JA. Giroldi LA, et al. Among authors: bringuier pp. Int J Cancer. 1999 Jul 2;82(1):70-6. doi: 10.1002/(sici)1097-0215(19990702)82:1<70::aid-ijc13>3.0.co;2-#. Int J Cancer. 1999. PMID: 10360823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters